FDA Application
-
NDC Search Results on Active Ingredient: aspirin
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
ASPIRIN | 46066-193-92 | Aspen Veterinary Resources, Ltd. | OTC ANIMAL DRUG | unapproved drug other | |
ASPIRIN | 46066-204-02 | Aspen Veterinary Resources, Ltd. | OTC ANIMAL DRUG | unapproved drug other | |
ASPIRIN | 53185-249-12 | Athlete's Needs Inc | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
CAFFEINE; ASPIRIN; ORPHENADRINE CITRATE | 71993-307-60 | Atland Pharmaceuticals, LLC | ANDA075141 | HUMAN PRESCRIPTION DRUG | ANDA |
ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE | 71993-304-60 | Atland Pharmaceuticals, LLC | ANDA075141 | HUMAN PRESCRIPTION DRUG | ANDA |
ASPIRIN | 17856-3086-1 | ATLANTIC BIOLOGICALS CORP. | part343 | HUMAN OTC DRUG | OTC MONOGRAPH NOT FINAL |
ASPIRIN | 17856-0922-2 | ATLANTIC BIOLOGICALS CORP. | M | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN | 17856-6794-1 | ATLANTIC BIOLOGICALS CORP. | M | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN | 17856-0922-1 | ATLANTIC BIOLOGICALS CORP. | M | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN | 17856-0901-1 | Atlantic Biologicals Corps | part343 | HUMAN OTC DRUG | OTC MONOGRAPH NOT FINAL |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 58602-882-21 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-36 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-14 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 58602-882-38 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-34 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-38 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-02 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-21 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-09 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-90 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-07 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
CAFFEINE; ACETAMINOPHEN; ASPIRIN | 58602-817-03 | Aurohealth LLC | ANDA211695 | HUMAN OTC DRUG | ANDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 69189-5135-1 | Avera McKennan Hospital | part343 | HUMAN OTC DRUG | OTC MONOGRAPH NOT FINAL |
ASPIRIN; DIPYRIDAMOLE | 42291-116-60 | AvKARE | ANDA206392 | HUMAN PRESCRIPTION DRUG | ANDA |
ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATE | 65662-005-01 | Bayer Bitterfeld GMBH | part343 | HUMAN OTC DRUG | OTC monograph not final |
ASPIRIN | 0280-0029-02 | Bayer HealthCare LLC | HUMAN OTC DRUG | Export only | |
ASPIRIN | 0280-0029-10 | Bayer HealthCare LLC | HUMAN OTC DRUG | Export only | |
ASPIRIN | 0280-0029-01 | Bayer HealthCare LLC | HUMAN OTC DRUG | Export only | |
ASPIRIN | 0280-2080-18 | Bayer HealthCare LLC. | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ASPIRIN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE BITARTRATE | 0280-1520-48 | Bayer HealthCare LLC. | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
-